Year: 2020

IDIBELL participates in the European Project Evomet, coordinated by IRB Barcelona, which will train future leaders in metastasis research

The goal is to train 15 young researchers in the understanding of metastatic processes and their evolution, with the aim to identify therapeutic solutions. The Evomet consortium is formed by 13 institutions, which include several of the best academic, clinical and industrial centres working in cancer research and metastasis research in Europe. Awarded in the …

IDIBELL participates in the European Project Evomet, coordinated by IRB Barcelona, which will train future leaders in metastasis research Read More »

IDIBELL scientists fins a new combination of drugs to treat rhabdomyosarcoma, a highly aggressive tumor in children

The chemoresistance group of IDIBELL and ICO’s ProCURE Program, led by Alberto Villanueva, has transferred its experience in generating orthotopic mouse models in adult patients to the pediatric field.

Scroll to Top